メインコンテンツにスキップ
検索

薬事戦略

登録

最新のリソース

注目コンテンツ

Upcoming strategic leadership webinars

Popular resources

以下のイベントで弊社のエキスパートをご紹介

展示会・学会

ISSX 2025 International Meeting

September 12 - 14, 2025 – Chicago, Illinois

All Strategic Leadership resources

Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning

Certara Services, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Therapeutic Specialties, Publication

From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara

Certara Services, Clinical Pharmacology, Drug Development, Drug Safety, Infectious Disease, Model Informed Drug Development, Model-Based Meta-Analysis (MBMA), Modeling and Simulation, Modeling and Simulation - PK/PD, Therapeutic Specialties, Webinar

Modernizing NCA Workflows: The Power of ADNCA for Regulatory-Ready Pharmacokinetic Analysis

Certara Products - Phoenix, Certara Products - Pinnacle 21, Certara Services, Clinical Pharmacology, Clinical Trials, Data Standards, Drug Development, Model Informed Drug Development, Modeling and Simulation - PK/PD, Webinar - Resources LP - Upcoming, Webinar

Bio International Convention 2025

展示会・学会

Introducing the new Certara.com: Transforming drug development for good, together.

Certara Products, Certara Services, Blog

Forbes: Adoption Of Model-Informed Drug Development Can Improve Pharma ROI

Model Informed Drug Development, Press Coverage

How Modeling Was Used to Support the FDA Approval of a Topical Generic Drug Product

pre-update, Press Coverage

Pharma Exec: MDMA Therapy for Mental Health Conditions

pre-update, Press Coverage

業界をリードするソフトウェアで学習者に能力をつける

Certara Products, Certara Products - Phoenix, pre-update, Fact Sheet

Industry Sense – Drug Repurposing Unlocking New Therapeutic Possibilities

pre-update, Press Coverage

ISSX 2025 International Meeting

Certara Products, Certara Products - Simcyp, Drug Development, Drug Safety, Drug-Drug Interactions (DDI), Modeling and Simulation - PBPK, Conference

Fierce Pharma – IRA biosimilar measure intended to boost uptake so far has ‘limited’ impact: report

pre-update, Press Coverage
ニュースレターを購読

今すぐ登録：医薬品開発の革新は、サターラの情熱そのものです。最新情報を入手し、ともに科学の限界を切り拓いていきましょう。


Powered by Translations.com GlobalLink Web Software